CYP3A4 and MDR1 alleles in a Portuguese population

被引:46
作者
Cavaco, I
Gil, JP
Gil-Berglund, E
Ribeiro, V
机构
[1] Univ Algarve, Fac Sci & Technol, CMQA, Mol Toxicol Lab, P-8000117 Faro, Portugal
[2] Karolinska Hosp, Karolinska Inst, Dept Med, Malaria Res Lab, S-10401 Stockholm, Sweden
[3] Univ Algarve, Fac Sci & Technol, Ctr Mol & Struct Biomed, Faro, Portugal
[4] Med Prod Agcy, Uppsala, Sweden
关键词
cytochrome P450; CYP3A4; MDR1; allele; polymorphism;
D O I
10.1515/CCLM.2003.206
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Polymorphisms in cytochrome P450 CYP3A4 and multidrug resistance (MDR)1 genes coding for the important drugmetabolising CYP3A4 and the ATPbinding cassette (ABC) transporter Pglycoprotein (Pgp) are poorly documented in the Portuguese population. In this study we have determined the frequencies of CYP3A4 and MDR1 alleles in Portuguese Caucasians. Both genes were simultaneously analysed as these genes are known to be frequently coinduced and their products to show a pronounced overlap of substrates. CYP3A4 A-392G (CYP3A4*1B), T673C (CYP3A4*2) and MDR1 T-129C, G2677T and C3435T single nucleotide polymorphisms (SNPs) were analysed in 100 individuals from the southern region of the country. We observed a frequency of 4.0% for CYP3A4*1B, not significantly different from that reported on other Caucasian European populations. CYP3A4*2 was found at an allele frequency of 4.5%, constituting the first report of the presence of this allele outside the Finnish population. Significant differences were found concerning the MDR1 C3435T SNP frequency (64.5%) compared with other European populations, while no differences were found concerning G2677T (47.5%) or T-129C (5%) SNPs. Linkage between the C3435T and G2677T SNPs was observed, although not as evidently as documented in other Caucasian populations. No preferential associations were detected between CYP3A4 and MDR1 alleles.
引用
收藏
页码:1345 / 1350
页数:6
相关论文
共 37 条
  • [1] NATURES CHEMICALS AND SYNTHETIC CHEMICALS - COMPARATIVE TOXICOLOGY .3.
    AMES, BN
    PROFET, M
    GOLD, LS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (19) : 7782 - 7786
  • [2] MDR1 pharmacogenetics:: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity
    Ameyaw, MM
    Regateiro, F
    Li, T
    Liu, XH
    Tariq, M
    Mobarek, A
    Thornton, N
    Folayan, GO
    Githang'a, J
    Indalo, A
    Ofori-Adjei, D
    Price-Evans, DA
    McLeod, HL
    [J]. PHARMACOGENETICS, 2001, 11 (03): : 217 - 221
  • [3] Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 - Response
    Amirimani, B
    Walker, AH
    Weber, BL
    Rebbeck, TR
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (18) : 1588 - 1590
  • [4] Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4
    Ando, Y
    Tateishi, T
    Sekido, Y
    Yamamoto, T
    Satoh, T
    Hasegawa, Y
    Kobayashi, S
    Katsumata, Y
    Shimokata, K
    Saito, H
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (18) : 1587 - 1588
  • [5] Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery
    Benet, LZ
    Izumi, T
    Zhang, YC
    Silverman, JA
    Wacher, VJ
    [J]. JOURNAL OF CONTROLLED RELEASE, 1999, 62 (1-2) : 25 - 31
  • [6] Mammalian ABC transporters in health and disease
    Borst, P
    Elferink, RO
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2002, 71 : 537 - 592
  • [7] Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects
    Cascorbi, I
    Gerloff, T
    Johne, A
    Meisel, C
    Hoffmeyer, S
    Schwab, M
    Schaeffeler, E
    Eichelbaum, M
    Brinkmann, U
    Roots, I
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) : 169 - 174
  • [8] The nuclear receptor PXR: A master regulator of "Homeland" Defense
    Dussault, I
    Forman, BM
    [J]. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2002, 12 (01): : 53 - 64
  • [9] Identification and functional characterization of eight CYP3A4 protein variants
    Eiselt, R
    Domanski, TL
    Zibat, A
    Mueller, R
    Presecan-Siedel, E
    Hustert, E
    Zanger, UM
    Brockmoller, J
    Klenk, HP
    Meyer, UA
    Khan, KK
    He, YA
    Halpert, JR
    Wojnowski, L
    [J]. PHARMACOGENETICS, 2001, 11 (05): : 447 - 458
  • [10] Association of CYP3A4 genotype with treatment-related leukemia
    Felix, CA
    Walker, AH
    Lange, BJ
    Williams, TM
    Winick, NJ
    Cheung, NKV
    Lovett, BD
    Nowell, PC
    Blair, IA
    Rebbeck, TR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (22) : 13176 - 13181